We are a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark.
Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, and rare blood and rare endocrine diseases.
We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure the diseases we treat.
We employ more than 44,000 people in 80 offices around the world, and market our products in 170 countries.
production sites in nine countries (Algeria, Brazil, China, Denmark, France, Japan, Russia, UK and US).
research and development centres in five countries (China, Denmark, India, UK and US).
of our employees are located in Denmark.
number of countries we provide access to our products.
Marie Darting and Pernille Thomasen, Novo Nordisk Denmark
In 1930, Novo delivered insulin to about 40 countries.